MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-500-14 |
Device Problems
Positioning Failure (1158); Activation, Positioning or Separation Problem (2906); Unintended Movement (3026)
|
Patient Problem
Intracranial Hemorrhage (1891)
|
Event Date 09/27/2022 |
Event Type
Death
|
Event Description
|
Medtronic received a report that the pipeline had movement during placement and difficulty with placement/positioning. the patient was undergoing surgery for treatment of an unruptured internal carotid artery (ica) aneurysm.It was noted the patient's vessel tortuosity was moderate.Dapt (dual antiplatelet treatment) was administered.The angiographic result post procedure was normal. it was reported that the pipeline was used for an indication that is approved (on-label).The pipeline and any accessory devices were prepared as indicated in the ifu. the pipeline had movement during placement and difficulty with placement/positioning.Multiple pipeline devices were not used when movement occurred.There was no friction or difficulty during delivery or positioning.The pipeline was implanted at the intended location.The pipeline did not miss the landing zone.The device did not jump during deployment.The pipeline was placed at least 3mm past the aneurysm neck on each side.It was unknown if any side branches were covered by the pipeline or if the tip of the catheter moved during deployment.The distal end of the device had difficulty opening and was successful after many attempts, balloon angioplasty was needed to complete.Post case images looked normal.Brain bleed occurred hours later.The patient passed away (b)(6) 2022.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that the movement of the device occurred during the attempts to open the device.The device had to be manipulated many times due to the difficult opening before a satisfactory placement was achieved.There was no friction during delivery.The hemorrhage was located in the ophthalmic region of the ica vessel.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|